178 related articles for article (PubMed ID: 29397459)
1. Tocilizumab for the treatment of birdshot uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy: two cases report and literature review.
Leclercq M; Le Besnerais M; Langlois V; Girszyn N; Benhamou Y; Ngo C; Levesque H; Muraine M; Gueudry J
Clin Rheumatol; 2018 Mar; 37(3):849-853. PubMed ID: 29397459
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Anti-IL6-Receptor Tocilizumab in Refractory Cystoid Macular Edema of Birdshot Retinochoroidopathy Report of Two Cases and Literature Review.
Calvo-Río V; Blanco R; Santos-Gómez M; Díaz-Valle D; Pato E; Loricera J; González-Vela MC; Demetrio-Pablo R; Hernández JL; González-Gay MA
Ocul Immunol Inflamm; 2017 Oct; 25(5):604-609. PubMed ID: 27726475
[TBL] [Abstract][Full Text] [Related]
3. Anti-TNF-α agents for refractory cystoid macular edema associated with noninfectious uveitis.
Schaap-Fogler M; Amer R; Friling R; Priel E; Kramer M
Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):633-40. PubMed ID: 24366669
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of tocilizumab therapy for refractory uveitis-related macular edema.
Mesquida M; Molins B; Llorenç V; Sainz de la Maza M; Adán A
Ophthalmology; 2014 Dec; 121(12):2380-6. PubMed ID: 25204610
[TBL] [Abstract][Full Text] [Related]
5. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients.
Vegas-Revenga N; Calvo-Río V; Mesquida M; Adán A; Hernández MV; Beltrán E; Valls Pascual E; Díaz-Valle D; Díaz-Cordovés G; Hernandez-Garfella M; Martínez-Costa L; Calvo I; Atanes A; Linares LF; Modesto C; González-Vela C; Demetrio-Pablo R; Aurrecoechea E; Cordero M; Domínguez-Casas LC; Atienza-Mateo B; Martín-Varillas JL; Loricera J; Palmou-Fontana N; Hernández JL; González-Gay MA; Blanco R
Am J Ophthalmol; 2019 Apr; 200():85-94. PubMed ID: 30660771
[TBL] [Abstract][Full Text] [Related]
6. Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis Network.
Leclercq M; Andrillon A; Maalouf G; Sève P; Bielefeld P; Gueudry J; Sené T; Moulinet T; Rouvière B; Sène D; Desbois AC; Domont F; Touhami S; El Chamieh C; Cacoub P; Bodaghi B; Biard L; Saadoun D
Ophthalmology; 2022 May; 129(5):520-529. PubMed ID: 34793830
[TBL] [Abstract][Full Text] [Related]
7. Tocilizumab treatment for refractory uveitis-related cystoid macular edema.
Adán A; Mesquida M; Llorenç V; Espinosa G; Molins B; Hernández MV; Pelegrín L
Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2627-32. PubMed ID: 23893042
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of tocilizumab in two patients with anti-TNF-alpha refractory uveitis.
Muselier A; Bielefeld P; Bidot S; Vinit J; Besancenot JF; Bron A
Ocul Immunol Inflamm; 2011 Oct; 19(5):382-3. PubMed ID: 21970668
[TBL] [Abstract][Full Text] [Related]
9. Adalimumab in refractory cystoid macular edema associated with birdshot chorioretinopathy.
Steeples LR; Spry P; Lee RWJ; Carreño E
Int Ophthalmol; 2018 Jun; 38(3):1357-1362. PubMed ID: 28608031
[TBL] [Abstract][Full Text] [Related]
10. IL-6 blockade in the management of non-infectious uveitis.
Lopalco G; Fabiani C; Sota J; Lucherini OM; Tosi GM; Frediani B; Iannone F; Galeazzi M; Franceschini R; Rigante D; Cantarini L
Clin Rheumatol; 2017 Jul; 36(7):1459-1469. PubMed ID: 28528519
[TBL] [Abstract][Full Text] [Related]
11. Tocilizumab for the Treatment of Behçet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy.
Eser Ozturk H; Oray M; Tugal-Tutkun I
Ocul Immunol Inflamm; 2018; 26(7):1005-1014. PubMed ID: 29020500
[TBL] [Abstract][Full Text] [Related]
12. Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients.
Calvo-Río V; Santos-Gómez M; Calvo I; González-Fernández MI; López-Montesinos B; Mesquida M; Adán A; Hernández MV; Maíz O; Atanes A; Bravo B; Modesto C; Díaz-Cordovés G; Palmou-Fontana N; Loricera J; González-Vela MC; Demetrio-Pablo R; Hernández JL; González-Gay MA; Blanco R
Arthritis Rheumatol; 2017 Mar; 69(3):668-675. PubMed ID: 27696756
[TBL] [Abstract][Full Text] [Related]
13. [Effectiveness of interferon alpha in the treatment of uveitis macular edema refractory to corticosteroid and/or immunosuppressive treatment].
Paire V; Lebreton O; Weber M
J Fr Ophtalmol; 2010 Mar; 33(3):152-62. PubMed ID: 20181409
[TBL] [Abstract][Full Text] [Related]
14. INTRAVITREAL DEXAMETHASONE IMPLANTATION FOR BIRDSHOT CHORIORETINOPATHY.
Walsh J; Reddy AK
Retin Cases Brief Rep; 2017 Winter; 11(1):51-55. PubMed ID: 26982209
[TBL] [Abstract][Full Text] [Related]
15. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.
Calvo-Río V; Blanco R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Hernandez Garfella M; Valls Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero Coma M; Díaz-Llopis M; Gallego R; Salom D; García Serrano JL; Ortego N; Herreras JM; Fonollosa A; García-Aparicio AM; Maíz O; Blanco A; Torre I; Fernández-Espartero C; Jovani V; Peiteado-Lopez D; Pato E; Cruz J; Fernández-Cid C; Aurrecoechea E; García M; Caracuel MA; Montilla C; Atanes A; Hernandez FF; Insua S; González-Suárez S; Sánchez-Andrade A; Gamero F; Linares L; Romero-Bueno F; García AJ; Almodovar R; Minguez E; Carrasco Cubero C; Olive A; Vázquez J; Ruiz Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernández S; Rueda-Gotor J; González-Gay MA
Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907
[TBL] [Abstract][Full Text] [Related]
16. Infliximab treatment of patients with birdshot retinochoroidopathy.
Artornsombudh P; Gevorgyan O; Payal A; Siddique SS; Foster CS
Ophthalmology; 2013 Mar; 120(3):588-592. PubMed ID: 23177362
[TBL] [Abstract][Full Text] [Related]
17. Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
Tappeiner C; Mesquida M; Adán A; Anton J; Ramanan AV; Carreno E; Mackensen F; Kotaniemi K; de Boer JH; Bou R; de Vicuña CG; Heiligenhaus A
J Rheumatol; 2016 Dec; 43(12):2183-2188. PubMed ID: 27633821
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive therapy for ocular diseases.
Jap A; Chee SP
Curr Opin Ophthalmol; 2008 Nov; 19(6):535-40. PubMed ID: 18854699
[TBL] [Abstract][Full Text] [Related]
19. Tocilizumab in severe and refractory non-infectious uveitis.
Papo M; Bielefeld P; Vallet H; Seve P; Wechsler B; Cacoub P; Le Hoang P; Papo T; Bodaghi B; Saadoun D
Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S75-9. PubMed ID: 25268663
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic noninfectious uveitis in children--the trend toward tumor necrosis factor-alpha inhibition.
Cunningham ET
J AAPOS; 2013 Oct; 17(5):451-3. PubMed ID: 24160960
[No Abstract] [Full Text] [Related]
[Next] [New Search]
